Thursday, October 23, 2025

Latest

Cognetivity: Utilizing AI for Early Alzheimer’s Intervention

Sina Habibi, Co-founder & CEO of Cognetivity Neurosciences (CSE: CGN) sits down with us today to discuss recent advancements in Alzheimer’s drugs, treatments and screening processes. We then transition into a discussion on Cognetitivty, including their main production offering, its involvement in the delivery of Alzheimer’s drugs, recent collaborations and agreements as well as what to watch for in the near term.

Cognetivity is a tech firm that has developed a cognitive testing platform for use in medical, commercial, and consumer environments. Through the use of AI and machine learning, the tech is able to detect the early onset of Alzheimer’s and dementia through testing the performance of large areas of the brain. The tech has acquired regulatory approval for use in both the UK and Europe, with further approvals in North America anticipated to occur.


FULL DISCLOSURE: Cognetivity Neurosciences is a former client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of Cognetivity Neurosciences. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

We Cannot Move To A Low-Carbon Economy Without Nuclear Energy — With Amir Adnani

Joining the Daily Dive today is Amir Adnani, CEO of Uranium Energy Corp. (NYSE: UEC)....

Tuesday, March 14, 2023, 01:30:00 PM

Gold Transactions Heating Up – The Daily Dive feat John-Mark Staude of Riverside Resources

Today on The Daily Dive, we are joined by our bi-weekly commentator John-Mark Staude, CEO...

Tuesday, January 5, 2021, 01:30:00 PM

XOUT: 2023 Market Outlook — With David Barse

Starting off The Daily Dive this week is David Barse, a returning guest and the...

Monday, March 6, 2023, 01:30:00 PM

Ventripoint: Uplisting To The OTCQB – The Daily Dive

Today on the Daily Dive, we are joined by George Adams, Chairman of Ventripoint Diagnostics...

Wednesday, January 19, 2022, 01:30:00 PM

Psyched Wellness Attracts Major Investment

Jeffrey Stevens, CEO & Director of Psyched Wellness (CSE: PSYC) joins us in today’s episode...

Friday, June 9, 2023, 01:30:00 PM